116 related articles for article (PubMed ID: 10656453)
41. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway.
Alonso M; Tamasdan C; Miller DC; Newcomb EW
Mol Cancer Ther; 2003 Feb; 2(2):139-50. PubMed ID: 12589031
[TBL] [Abstract][Full Text] [Related]
42. The benzoylurea derivative F13 inhibits cell growth, migration and invasion through inducing expression of ERK1/2-mediated RECK in fibrosarcoma HT-1080 cells.
Jin H; Ren K; He HW; Liu X; Song DQ; Shao RG
Anticancer Drugs; 2010 Apr; 21(4):372-80. PubMed ID: 20051826
[TBL] [Abstract][Full Text] [Related]
43. Bcl-2 independence of flavopiridol-induced apoptosis. Mitochondrial depolarization in the absence of cytochrome c release.
Achenbach TV; Müller R; Slater EP
J Biol Chem; 2000 Oct; 275(41):32089-97. PubMed ID: 10896673
[TBL] [Abstract][Full Text] [Related]
44. Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPL.
Fandy TE; Ross DD; Gore SD; Srivastava RK
Cancer Chemother Pharmacol; 2007 Aug; 60(3):313-9. PubMed ID: 17187253
[TBL] [Abstract][Full Text] [Related]
45. Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells.
Wiechen K; Karaaslan S; Turzynski A; Dietel M
Br J Cancer; 1999 Nov; 81(5):790-5. PubMed ID: 10555747
[TBL] [Abstract][Full Text] [Related]
46. Apoptosis induction and potent antiestrogen receptor-negative breast cancer activity in vivo by a retinoid antagonist.
Fanjul AN; Piedrafita FJ; Al-Shamma H; Pfahl M
Cancer Res; 1998 Oct; 58(20):4607-10. PubMed ID: 9788611
[TBL] [Abstract][Full Text] [Related]
47. In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from flax lignan, and down-regulation of matrix metalloproteinases in MCF-7 and MDA MB 231 cell lines.
Mali AV; Wagh UV; Hegde MV; Chandorkar SS; Surve SV; Patole MV
Indian J Cancer; 2012; 49(1):181-7. PubMed ID: 22842186
[TBL] [Abstract][Full Text] [Related]
48. Flavopiridol, a cyclin dependent kinase (CDK) inhibitor, induces apoptosis by regulating Bcl-x in oral cancer cells.
Mihara M; Shintani S; Nakashiro K; Hamakawa H
Oral Oncol; 2003 Jan; 39(1):49-55. PubMed ID: 12457721
[TBL] [Abstract][Full Text] [Related]
49. DLBS1425, a Phaleria macrocarpa (Scheff.) Boerl. extract confers anti proliferative and proapoptosis effects via eicosanoid pathway.
Tjandrawinata RR; Arifin PF; Tandrasasmita OM; Rahmi D; Aripin A
J Exp Ther Oncol; 2010; 8(3):187-201. PubMed ID: 20734918
[TBL] [Abstract][Full Text] [Related]
50. A novel human xenograft model of inflammatory breast cancer.
Alpaugh ML; Tomlinson JS; Shao ZM; Barsky SH
Cancer Res; 1999 Oct; 59(20):5079-84. PubMed ID: 10537277
[TBL] [Abstract][Full Text] [Related]
51. The human myoepithelial cell is a natural tumor suppressor.
Sternlicht MD; Kedeshian P; Shao ZM; Safarians S; Barsky SH
Clin Cancer Res; 1997 Nov; 3(11):1949-58. PubMed ID: 9815584
[TBL] [Abstract][Full Text] [Related]
52. Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells.
Ali S; El-Rayes BF; Aranha O; Sarkar FH; Philip PA
Breast Cancer Res Treat; 2005 Mar; 90(1):25-31. PubMed ID: 15770523
[TBL] [Abstract][Full Text] [Related]
53. Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol.
Semenov I; Akyuz C; Roginskaya V; Chauhan D; Corey SJ
Leuk Res; 2002 Mar; 26(3):271-80. PubMed ID: 11792416
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional signature of flavopiridol-induced tumor cell death.
Lü X; Burgan WE; Cerra MA; Chuang EY; Tsai MH; Tofilon PJ; Camphausen K
Mol Cancer Ther; 2004 Jul; 3(7):861-72. PubMed ID: 15252147
[TBL] [Abstract][Full Text] [Related]
55. Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.
Roetger A; Merschjann A; Dittmar T; Jackisch C; Barnekow A; Brandt B
Am J Pathol; 1998 Dec; 153(6):1797-806. PubMed ID: 9846970
[TBL] [Abstract][Full Text] [Related]
56. Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity In vivo against human leukemia and lymphoma xenografts.
Arguello F; Alexander M; Sterry JA; Tudor G; Smith EM; Kalavar NT; Greene JF; Koss W; Morgan CD; Stinson SF; Siford TJ; Alvord WG; Klabansky RL; Sausville EA
Blood; 1998 Apr; 91(7):2482-90. PubMed ID: 9516149
[TBL] [Abstract][Full Text] [Related]
57. Effects of flavopiridol on critical regulation pathways of CD133high/CD44high lung cancer stem cells.
Bozok Cetintas V; Acikgoz E; Yigitturk G; Demir K; Oktem G; Tezcanli Kaymaz B; Oltulu F; Aktug H
Medicine (Baltimore); 2016 Oct; 95(43):e5150. PubMed ID: 27787370
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts.
Chen D; Landis-Piwowar KR; Chen MS; Dou QP
Breast Cancer Res; 2007; 9(6):R80. PubMed ID: 18300387
[TBL] [Abstract][Full Text] [Related]
59. Effect of P-glycoprotein on flavopiridol sensitivity.
Boerner SA; Tourne ME; Kaufmann SH; Bible KC
Br J Cancer; 2001 May; 84(10):1391-6. PubMed ID: 11355953
[TBL] [Abstract][Full Text] [Related]
60. Sequential combination therapy with flavopiridol and autocatalytic caspase-3 driven by amplified hTERT promoter synergistically suppresses human ovarian carcinoma growth in vitro and in mice.
Song Y; Xin X; Zhai X; Xia Z; Shen K
J Ovarian Res; 2014 Dec; 7():121. PubMed ID: 25528169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
